Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocuronium-Sugammadex vs Succinylcholine for Short Surgical Procedures
NCT00751179Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2008
- Primary completion
- Dec 2009
- Modality
- Biodegradable Polymers, Small Molecules
01
Overview
A Phase 3 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Merck & Co.. Started Nov 2008; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT00751179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00751179.